Oral Supplementation of Astaxanthin on Skin Photoaging, Hydration and Elasticity
NCT ID: NCT05882084
Last Updated: 2023-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2023-07-24
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Effect of Astaxanthin in Healthy Participants
NCT05376501
Effects of an Oral Herbal Supplement on Skin Aging, Hydration, and Elasticity
NCT06146140
Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly
NCT03368872
The Effects of a Longevity Supplement on Aging and Photoaging
NCT05262036
Evaluation of Astaxanthin Properties on Anti-fatigue
NCT06593535
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Astaxanthin
6 mg daily
Astaxanthin 6 mg daily
Astaxanthin at 6 mg is given for daily ingestion and compared against placebo.
Placebo
Placebo
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Astaxanthin 6 mg daily
Astaxanthin at 6 mg is given for daily ingestion and compared against placebo.
Placebo
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Half of the women will have Fitzpatrick skin type 1-3 and the other half of the women will have Fitzpatrick skin type 4-6
Exclusion Criteria
* Individuals who are unwilling to discontinue carotenoid supplementation for at least 1 month prior to enrollment
* Individuals unwilling to restrict intake of foods like shrimp, salmon, mangos, carrots, and tomatoes during the study.
* New supplementation within 4 weeks with tocopherol
* Individuals who are unwilling to stay consistent with a facial cleansing regimen.
* Those who are unwilling to discontinue topical hydroquinone, retinoid or benzoyl peroxide for 2 weeks prior to enrollment
* Individuals who are pregnant or breastfeeding.
* Individuals who have changed any of their hormonal based contraception within 3 months prior to joining the study.
* Current tobacco smoker or a tobacco smoking history of greater than 10 pack-years
30 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstaReal
UNKNOWN
Integrative Skin Science and Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raja Sivamani, MD MS AP
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raja Sivamani, MD
Role: PRINCIPAL_INVESTIGATOR
Integrative Skin Science and Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Integrative Skin Science and Research
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Asta_Skin_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.